drug

landiolol hydrochloride

Marketedupdated 2mo ago

by AOP Health

Approved

community read0 votes

indications

investigational

Atrial Fibrillation

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

Patent cliff

source: FDA Orange Book

first barrier falls

Feb 13, 2029

~2.6 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (1)

Apr 25, 2034method-of-use (U-4235)US 10722516

FDA exclusivities (2)

Nov 22, 2029NCENew Chemical Entity (5y)3.4y
Feb 13, 2029NPPNew Product (3y)2.6y

🐶 often sniffed alongside

top 1

tagApproval8 co-mentions · 2 sources